Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionSilicon Valley Capital Partners
Latest Disclosed Ownership276 shares
Latest Disclosed Value $ 10,143
Silicon Valley Capital Partners ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 19, 2026 - Silicon Valley Capital Partners filed a 13F-HR form disclosing ownership of 276 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $8,708 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 276 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $9,886 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-19 2026-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 276 0 0.00 10 -28.57 0.0010
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 276 0 0.00 14 -6.67 0.0013
2025-11-17 2025-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 276 276 15 0.0014
2025-09-11 2025-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 0 -738 -100.00 0 -100.00
2025-05-28 2025-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 738 0 0.00 51 -19.05 0.0067
2025-01-29 2024-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 738 -802 -52.08 64 -65.57 0.0071
2024-10-30 2024-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 1,540 4 0.26 183 -16.44 0.0239
2024-10-30 2024-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 1,536 804 109.84 219 132.98 0.0302
2024-04-29 2024-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 732 0 0.00 94 25.33 0.0140
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 732 0 0.00 76 13.64 0.0127
2023-11-06 2023-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 732 367 100.55 67 11.86 0.0125
2023-08-14 2023-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 365 365 59 0.0110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.